C07K 14/175
Bunyaviridae
Official title: Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus
C07K14/175 (Bunyaviridae) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C07K- Granted patents
- 4
- Published applications
- 8
- Assignees
- 12
- Inventors
- 27
- Latest grant
- 16 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus and use for same16 Mar 2021US 10,947,299 B2Institut Pasteur Korea
- Antiviral rift valley fever virus peptides and methods of use31 Jan 2017US 9,556,237 B2The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases
- Pathogenic phlebovirus isolates and compositions and methods of use23 Aug 2016US 9,421,250 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and reagents for diagnosing hantavirus infection10 Aug 2010US 7,771,730 B2Novartis Vaccines and Diagnostics, Inc.
- Mrna vaccine for bandavirus dabieense and preparation method thereof6 Nov 2025US 2025/0339507 A1Nanjing Medical University
- Antibody that binds to envelope glycoprotein of sever fever with thrombocytopenia syndrome virus and use for same10 Jun 2021US 2021/0171611 A1Institut Pasteur Korea
- Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus and use for same18 Apr 2019US 2019/0112360 A1Institut Pasteur Korea
- Antiviral rift valley fever virus peptides and methods of use26 Nov 2015US 2015/0337015 A1The United States of America, as represented by the Secretary of the Army, on behalf of the United
- Pathogenic phlebovirus isolates and compositions and methods of use26 Mar 2015US 2015/0086577 A1The Government of the United States of America as represented by the Secretary of the Department of
Most cited
By later US patents
- Antiviral rift valley fever virus peptides and methods of use8US 9,556,237 B2The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases · 2017
- Pathogenic phlebovirus isolates and compositions and methods of use1US 9,421,250 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016